DiaMedica Therapeutics Inc.DMACNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +12.65% | +12.81% | +12.87% | +12.84% | +16.09% |
| Weighted Average Shares Diluted Growth | +12.65% | +12.81% | +12.87% | +12.84% | +16.09% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -36.04% | -36.59% | -58.82% | -10.34% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -9.66% | -14.43% | -21.17% | -44.59% | +8.61% |
| Book Value per Share Growth | -23.46% | -29.30% | -35.10% | -54.92% | -7.29% |
| Debt Growth | -13.10% | -15.00% | -16.84% | -24.74% | -27.12% |
| R&D Expense Growth | +52.29% | +75.96% | +53.86% | +48.22% | +29.18% |
| SG&A Expenses Growth | +0.80% | -10.40% | +20.48% | +27.78% | +35.68% |